Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P40200
UPID:
TACT_HUMAN
Alternative names:
Cell surface antigen CD96; T cell-activated increased late expression protein
Alternative UPACC:
P40200; Q5JPB3
Background:
T-cell surface protein tactile, also known as CD96, plays a crucial role in the immune response. It is involved in adhesive interactions of activated T and NK cells during the late phase of the immune response, facilitating NK cell-target adhesion by interacting with PVR on target cells. This interaction is vital after T and NK cells have penetrated the endothelium, engaging diseased cells within areas of inflammation.
Therapeutic significance:
CD96 is implicated in C syndrome, characterized by a range of physical and cognitive abnormalities due to gene variants affecting CD96. Understanding the role of T-cell surface protein tactile could open doors to potential therapeutic strategies for managing C syndrome and enhancing immune response precision.